Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Fas-L promotes the stem cell potency of adipose-derived mesenchymal cells.

Solodeev I, Meilik B, Volovitz I, Sela M, Manheim S, Yarkoni S, Zipori D, Gur E, Shani N.

Cell Death Dis. 2018 Jun 11;9(6):695. doi: 10.1038/s41419-018-0702-y.

2.

Re-exposure to nicotine-associated context from adolescence enhances alcohol intake in adulthood.

Zipori D, Sadot-Sogrin Y, Goltseker K, Even-Chen O, Rahamim N, Shaham O, Barak S.

Sci Rep. 2017 May 30;7(1):2479. doi: 10.1038/s41598-017-02177-2.

3.

Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins.

Schieferdecker A, Shoshani O, Westner B, Zipori D, Fehse B, Kröger N, Ayuk F.

Oncotarget. 2016 Oct 11;7(41):67061-67070. doi: 10.18632/oncotarget.11489.

4.

Cultured Mesenchymal Stem Cells Stimulate an Immune Response by Providing Immune Cells with Toll-Like Receptor 2 Ligand.

Weinstock A, Pevsner-Fischer M, Porat Z, Selitrennik M, Zipori D.

Stem Cell Rev Rep. 2015 Dec;11(6):826-40. doi: 10.1007/s12015-015-9614-8.

PMID:
26250539
5.

NOX1-induced accumulation of reactive oxygen species in abdominal fat-derived mesenchymal stromal cells impinges on long-term proliferation.

Sela M, Tirza G, Ravid O, Volovitz I, Solodeev I, Friedman O, Zipori D, Gur E, Krelin Y, Shani N.

Cell Death Dis. 2015 Apr 16;6:e1728. doi: 10.1038/cddis.2015.84.

6.

Relative genomic stability of adipose tissue derived mesenchymal stem cells: analysis of ploidy, H19 long non-coding RNA and p53 activity.

Ravid O, Shoshani O, Sela M, Weinstock A, Sadan TW, Gur E, Zipori D, Shani N.

Stem Cell Res Ther. 2014 Dec 17;5(6):139. doi: 10.1186/scrt529.

7.

Stress as a fundamental theme in cell plasticity.

Shoshani O, Zipori D.

Biochim Biophys Acta. 2015 Apr;1849(4):371-7. doi: 10.1016/j.bbagrm.2014.07.006. Epub 2014 Jul 16. Review.

PMID:
25038585
8.

Cell isolation induces fate changes of bone marrow mesenchymal cells leading to loss or alternatively to acquisition of new differentiation potentials.

Shoshani O, Ravid O, Massalha H, Aharonov A, Ovadya Y, Pevsner-Fischer M, Leshkowitz D, Zipori D.

Stem Cells. 2014 Aug;32(8):2008-20. doi: 10.1002/stem.1719.

9.

Divergent levels of LBP and TGFβ1 in murine MSCs lead to heterogenic response to TLR and proinflammatory cytokine activation.

Levin S, Pevsner-Fischer M, Kagan S, Lifshitz H, Weinstock A, Gataulin D, Friedlander G, Zipori D.

Stem Cell Rev Rep. 2014 Jun;10(3):376-88. doi: 10.1007/s12015-014-9498-z.

PMID:
24664302
10.

Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFκB with a characteristic transcriptional signature.

Mizrahi K, Kagan S, Stein J, Yaniv I, Zipori D, Askenasy N.

Stem Cells Dev. 2014 Mar 15;23(6):676-86. doi: 10.1089/scd.2013.0270. Epub 2013 Dec 31.

PMID:
24200242
11.

The origin of human mesenchymal stromal cells dictates their reparative properties.

Naftali-Shani N, Itzhaki-Alfia A, Landa-Rouben N, Kain D, Holbova R, Adutler-Lieber S, Molotski N, Asher E, Grupper A, Millet E, Tessone A, Winkler E, Kastrup J, Feinberg MS, Zipori D, Pevsner-Fischer M, Raanani E, Leor J.

J Am Heart Assoc. 2013 Sep 30;2(5):e000253. doi: 10.1161/JAHA.113.000253.

12.

Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity.

Shoshani O, Massalha H, Shani N, Kagan S, Ravid O, Madar S, Trakhtenbrot L, Leshkowitz D, Rechavi G, Zipori D.

Cancer Res. 2012 Dec 15;72(24):6403-13. doi: 10.1158/0008-5472.CAN-12-1155. Epub 2012 Oct 9.

13.

Mitochondria as a sequestration site for incomplete TCRβ peptides: the TCRβ transmembrane domain is a sufficient mitochondrial targeting signal.

Shani N, Shinder V, Zipori D.

Mol Immunol. 2011 Oct;49(1-2):239-52. doi: 10.1016/j.molimm.2011.08.018. Epub 2011 Sep 23.

PMID:
21943707
14.

Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factor.

Pevsner-Fischer M, Levin S, Hammer-Topaz T, Cohen Y, Mor F, Wagemaker G, Nagler A, Cohen IR, Zipori D.

Stem Cell Rev Rep. 2012 Jun;8(2):343-54. doi: 10.1007/s12015-011-9310-2.

PMID:
21881833
15.

[Towards a molecular rather than a descriptive definition of stemness].

Zipori D.

Med Sci (Paris). 2011 Mar;27(3):303-7. doi: 10.1051/medsci/2011273303. Epub 2011 Mar 30. French.

16.

The origins of mesenchymal stromal cell heterogeneity.

Pevsner-Fischer M, Levin S, Zipori D.

Stem Cell Rev Rep. 2011 Sep;7(3):560-8. doi: 10.1007/s12015-011-9229-7. Review.

PMID:
21437576
17.

Mammalian cell dedifferentiation as a possible outcome of stress.

Shoshani O, Zipori D.

Stem Cell Rev Rep. 2011 Sep;7(3):488-93. doi: 10.1007/s12015-011-9231-0. Review.

PMID:
21279479
18.

Transition of endothelium to cartilage and bone.

Shoshani O, Zipori D.

Cell Stem Cell. 2011 Jan 7;8(1):10-1. doi: 10.1016/j.stem.2010.12.004.

19.

The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell.

Zipori D.

Cancer Microenviron. 2010 Feb 5;3(1):15-28. doi: 10.1007/s12307-009-0034-7.

20.

Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.

Dezorella N, Pevsner-Fischer M, Deutsch V, Kay S, Baron S, Stern R, Tavor S, Nagler A, Naparstek E, Zipori D, Katz BZ.

Exp Cell Res. 2009 Jul 1;315(11):1904-13. doi: 10.1016/j.yexcr.2009.03.016. Epub 2009 Mar 27.

PMID:
19328780
21.

The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation.

Abraham M, Beider K, Wald H, Weiss ID, Zipori D, Galun E, Nagler A, Eizenberg O, Peled A.

Leukemia. 2009 Aug;23(8):1378-88. doi: 10.1038/leu.2009.56. Epub 2009 Mar 26.

PMID:
19322207
22.

p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.

Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A, Tzahor E, Lozano G, Zipori D, Sarig R, Rotter V.

PLoS One. 2008;3(11):e3707. doi: 10.1371/journal.pone.0003707. Epub 2008 Nov 12.

23.

Incomplete T-cell receptor-beta peptides target the mitochondrion and induce apoptosis.

Shani N, Rubin-Lifshitz H, Peretz-Cohen Y, Shkolnik K, Shinder V, Cohen-Sfady M, Shav-Tal Y, Barda-Saad M, Zipori D.

Blood. 2009 Apr 9;113(15):3530-41. doi: 10.1182/blood-2008-07-171405. Epub 2008 Oct 17.

PMID:
18931338
24.
25.

The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation.

Morad V, Pevsner-Fischer M, Barnees S, Samokovlisky A, Rousso-Noori L, Rosenfeld R, Zipori D.

Stem Cells. 2008 Sep;26(9):2275-86. doi: 10.1634/stemcells.2007-0518. Epub 2008 Jun 12.

26.

Blood to brain yet again.

Zipori D.

Blood. 2008 Jun 15;111(12):5422-3. doi: 10.1182/blood-2008-02-140897. No abstract available.

PMID:
18544692
27.

Targeting the bone marrow with activin A-overexpressing embryonic multipotent stromal cells specifically modifies B lymphopoiesis.

Parameswaran R, Morad V, Laronne A, Rousso-Noori L, Shani N, Naffar-Abu-Amara S, Zipori D.

Stem Cells Dev. 2008 Feb;17(1):93-106. doi: 10.1089/scd.2007.0099.

PMID:
18225977
28.

The stem state: mesenchymal plasticity as a paradigm.

Zipori D.

Curr Stem Cell Res Ther. 2006 Jan;1(1):95-102. Review.

PMID:
18220858
29.
30.

The stem state: the nature of normal stem cells and the relevance to cancer.

Zipori D.

J Stem Cells Regen Med. 2007 May 16;2(1):29-30. eCollection 2007. No abstract available.

PMID:
24692888
32.

Toll-like receptors and their ligands control mesenchymal stem cell functions.

Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, Cohen S, Cohen IR, Zipori D.

Blood. 2007 Feb 15;109(4):1422-32. Epub 2006 Oct 12.

PMID:
17038530
33.
34.
35.

Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition.

Shav-Tal Y, Blechman J, Darzacq X, Montagna C, Dye BT, Patton JG, Singer RH, Zipori D.

Mol Biol Cell. 2005 May;16(5):2395-413. Epub 2005 Mar 9.

36.

Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair.

Zipori D.

Blood Cells Mol Dis. 2004 Nov-Dec;33(3):211-5. Review.

PMID:
15528133
37.

The nature of stem cells: state rather than entity.

Zipori D.

Nat Rev Genet. 2004 Nov;5(11):873-8. doi: 10.1038/nrg1475. Review.

PMID:
15520797
38.

Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm.

Prindull G, Zipori D.

Blood. 2004 Apr 15;103(8):2892-9. Epub 2004 Jan 8. Review.

PMID:
15070660
39.

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J.

Circulation. 2003 Aug 19;108(7):863-8. Epub 2003 Aug 4.

PMID:
12900340
40.

The mesenchymal stroma negatively regulates B cell lymphopoiesis through the expression of activin A.

Shoham T, Parameswaran R, Shav-Tal Y, Barda-Saad M, Zipori D.

Ann N Y Acad Sci. 2003 May;996:245-60.

PMID:
12799303
41.

The role of activin a in regulation of hemopoiesis.

Shav-Tal Y, Zipori D.

Stem Cells. 2002;20(6):493-500. Review.

42.

PSF and p54(nrb)/NonO--multi-functional nuclear proteins.

Shav-Tal Y, Zipori D.

FEBS Lett. 2002 Nov 6;531(2):109-14. Review.

43.

Meeting summary: European Workshop on Stem Cells, European Centre for the Validation of Biomedical Testing Methods, Institute for Health and Consumer Protection, Joint Research Centre, Ispra, Italy, November 21-23, 2001.

Gribaldo L, Alison M, Andrews PW, Bremer S, Donovan PJ, Knaän-Shanzer S, Mertelsmann R, Spielmann H, Testa NG, Triffitt JT, Zipori D, de Wynter E.

Exp Hematol. 2002 Jul;30(7):628-33. No abstract available.

PMID:
12135658
44.

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L, Ponomaryov T, Taichman RS, Arenzana-Seisdedos F, Fujii N, Sandbank J, Zipori D, Lapidot T.

Nat Immunol. 2002 Jul;3(7):687-94. Epub 2002 Jun 17. Erratum in: Nat Immunol 2002 Aug;3(8):787.

PMID:
12068293
45.

The mesenchyme expresses T cell receptor mRNAs: relevance to cell growth control.

Barda-Saad M, Shav-Tal Y, Rozenszajn AL, Cohen M, Zauberman A, Karmazyn A, Parameswaran R, Schori H, Ashush H, Ben-Nun A, Zipori D.

Oncogene. 2002 Mar 27;21(13):2029-36.

46.

Reduced expression of activin A in focal lymphoid agglomerates within nasal polyps.

Shoham T, Yaniv E, Koren R, Gal R, Parameswaran R, Kravitz A, Geron H, Markovitz D, Lantzki M, Zipori D.

J Histochem Cytochem. 2001 Oct;49(10):1245-52.

PMID:
11561008
47.
48.

The promotion of plasmacytoma tumor growth by mesenchymal stroma is antagonized by basic fibroblast growth factor induced activin A.

Shoham T, Sternberg D, Brosh N, Krupsky M, Barda-Saad M, Zipori D.

Leukemia. 2001 Jul;15(7):1102-10.

49.

Role of activin A in negative regulation of normal and tumor B lymphocytes.

Zipori D, Barda-Saad M.

J Leukoc Biol. 2001 Jun;69(6):867-73. Review.

PMID:
11404369
50.

Supplemental Content

Loading ...
Support Center